Mangoceuticals (MGRX) Net Cash Flow Growth (3y) (2026)
Mangoceuticals (MGRX) Net Cash Flow Growth (3y) (2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 32.00 Bn | 24.69 Bn | 662.02 Mn | 31.95% |
| 2 | BrightSpring Health Services | 14.72 Bn | 13.82 Bn | 482.22 Mn | 590.29% |
| 3 | Healthequity | 8.29 Bn | 8.02 Bn | 256.31 Mn | -23.22% |
| 4 | Hinge Health | 5.99 Bn | 5.67 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 5.92 Bn | 5.38 Bn | 106.18 Mn | -47.37% |
| 6 | MiniMed | 4.51 Bn | 4.22 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.47 Bn | 4.41 Bn | 216.84 Mn | - |
| 8 | Doximity | 3.95 Bn | 3.20 Bn | 125.97 Mn | 92.69% |
| 9 | Privia Health | 3.15 Bn | 2.73 Bn | - | -17.84% |
| 10 | Mangoceuticals | 8.99 Mn | 8.80 Mn | 29,001.00 | -34.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.10% |